Prm58 - Impact of Future Costs in Cost-Effectiveness Analyses and a Comparison of Direct and Indirect Methods Using Models of Cabazitaxel in Prostate Cancer and Clopidogrel in Acute Coronary Syndrome

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2180
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness Analyses and Cost Analyses in Castration-Resistant Prostate Cancer: A Systematic Review

PLoS ONE
Multidisciplinary
2018English

Comparison of Atrial Fibrillation Predictors in Patients With Acute Coronary Syndrome Using Ticagrelor or Clopidogrel

Turkish Journal of Medical Sciences
Medicine
2019English

Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies in Acute Coronary Syndrome

Annals of Internal Medicine
Internal MedicineMedicine
2014English

Cost-Effectiveness of Ticagrelor Versus Clopidogrel for the Prevention of Atherothrombotic Events in Adult Patients With Acute Coronary Syndrome in Germany

Clinical Research in Cardiology
MedicineCardiovascular MedicineCardiology
2013English

Future Costs and the Future of Cost-Effectiveness Analysis

Journal of Health Economics
Health PolicyPublic HealthOccupational HealthEnvironmental
2008English

Pcv61 - Productivity Loss and Local Indirect Costs Associated With Acute Coronary Syndrome and Stroke in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of Cyp2c19*2 Genotype Guided Selection of Clopidogrel or Ticagrelor in Hong Kong Chinese Patients With Acute Coronary Syndrome

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Cost-Effectiveness of Treating Acute Coronary Syndrome Patients With Rivaroxban in Australia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Rationale and Role of High Loading Dose Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Pharmacology & Pharmacy
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy